A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)
Clinical trial NCT03385226 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03385226
- Sponsor
- University College, London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-15
- Primary completion
- 2023-09-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.